Professur für Molekulare Mechanismen der Organfibrose

Nintedanib reduces alloimmune-induced chronic airway changes in murine tracheal allografts (2022) Mauer J, Kuckhahn A, Ramsperger-Gleixner M, Ensminger SM, Distler J, Weyand M, Heim C Journal article Erratum to: Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: A study from the EUSTAR cohort(Rheumatology 2021DOI: 10.1093/rheumatology/keab510) (2022) Hughes M, Heal C, Henes J, Balbir-Gurman A, Distler J, Airo P, Mueller-Ladner U, et al. Journal article, Erratum Deciphering Pro-angiogenic Transcription Factor Profiles in Hypoxic Human Endothelial Cells by Combined Bioinformatics and in vitro Modeling (2022) Schmidt A, Fuchs M, Stojanović SD, Liang C, Schmidt K, Jung M, Xiao K, et al. Journal article CLINICAL CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH SYSTEMIC SCLEROSIS SINE SCLERODERMA: DATA FROM THE INTERNATIONAL EUSTAR DATABASE. (2022) Lescoat A, Huang S, Carreira P, Siegert E, De Vries-Bouwstra J, Distler J, Smith V, et al. Conference contribution GLUCOCORTICOIDS PRESCRIBING PRACTICES IN SYSTEMIC SCLEROSIS: AN ANALYSIS OF THE EUSTAR DATABASE. (2022) Iudici M, Mongin D, Siegert E, Carreira P, Distler J, Henes J, Zanatta E, et al. Conference contribution PERSISTENT INFLAMMATION IN SYSTEMIC SCLEROSIS IS STRONGLY ASSOCIATED WITH SEVERE DISEASE AND MORTALITY: AN ANALYSIS FROM THE EUSTAR DATABASE (2022) Sarbu AC, Guler S, Stadler O, Allanore Y, Bernardino V, Distler J, Gabrielli A, et al. Conference contribution "EFFECTIVE LUNG AGE" IN SUBJECTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) IN THE SENSCIS TRIAL (2022) Maher T, Bourdin A, Volkmann E, Vettori S, Distler J, Alves M, Stock C, Distler O Conference contribution DEVELOPING A SCREENING TOOL FOR THE DETECTION OF INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS:THE ILD-RISC RISK SCORE (2022) Bruni C, Tofani L, Fretheim H, Liem S, Velauthapillai A, Bjorkekjaer J, Barua I, et al. Conference contribution TEMPORAL MIGRATION OF IMMUNE CELLS FROM PSORIATIC SKIN TO JOINTS INITIATING SYNOVIAL INFLAMMATION IN PSORIATIC ARTHRITIS (2022) Raimondo MG, Rauber S, Xu C, Mohammadian H, Vogg M, Anchang CG, Rigau A, et al. Conference contribution DERSIMELAGON, A NOVEL ORAL MELANOCORTIN 1 RECEPTOR AGONIST, DEMONSTRATES DISEASE-MODIFYING EFFECTS IN PRECLINICAL MODELS OF SYSTEMIC SCLEROSIS (2022) Kondo M, Suzuki T, Kawano Y, Kojima S, Miyashiro M, Matsumoto A, Kania G, et al. Journal article